Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (NHPAP) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for National Healthcare Properties (NHPAP) over the last 13 years, with Q3 2025 value amounting to -$15.9 million.

  • National Healthcare Properties' Net Income towards Common Stockholders rose 6402.29% to -$15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.5 million, marking a year-over-year increase of 6899.29%. This contributed to the annual value of -$203.5 million for FY2024, which is 13635.55% down from last year.
  • National Healthcare Properties' Net Income towards Common Stockholders amounted to -$15.9 million in Q3 2025, which was up 6402.29% from -$24.2 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare Properties' Net Income towards Common Stockholders peaked at -$5.0 million during Q1 2025, and registered a low of -$119.9 million during Q2 2024.
  • Its 5-year average for Net Income towards Common Stockholders is -$27.4 million, with a median of -$21.1 million in 2022.
  • As far as peak fluctuations go, National Healthcare Properties' Net Income towards Common Stockholders tumbled by 47765.79% in 2024, and later surged by 7982.84% in 2025.
  • National Healthcare Properties' Net Income towards Common Stockholders (Quarter) stood at -$22.8 million in 2021, then rose by 2.78% to -$22.1 million in 2022, then decreased by 27.76% to -$28.3 million in 2023, then rose by 27.7% to -$20.4 million in 2024, then increased by 22.29% to -$15.9 million in 2025.
  • Its last three reported values are -$15.9 million in Q3 2025, -$24.2 million for Q2 2025, and -$5.0 million during Q1 2025.